Immix Biopharma, Inc. Share Price
IMMX$0.00
+0.00 (0.00%) Immix Biopharma, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Immix Biopharma, Inc. Share Price Chart
$0.00
Please wait...
About Immix Biopharma, Inc.
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Immix Biopharma, Inc. Historical Data
| Day | Open | Close | Change % |
|---|
FAQs on Immix Biopharma, Inc. Share Price
Can I buy Immix Biopharma, Inc. shares in India?
Yes. You can buy Immix Biopharma, Inc. in India by opening an international trading account.
What is the share price of Immix Biopharma, Inc.?
As on 08 Feb '26, the share price of Immix Biopharma, Inc. IMMX is $0.00. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.
What is the 5 year returns of Immix Biopharma, Inc.?
The 5 year returns of Immix Biopharma, Inc. is as on 08 Feb '26.
What are the high & low stock price of Immix Biopharma, Inc. today?
Immix Biopharma, Inc. stock price hit a high of $0.00 and low of $0.00 as on 08 Feb '26.
What is the 52-week high and low of Immix Biopharma, Inc. stock?
The 52-week high of Immix Biopharma, Inc. stock is $0.00, while the 52-week low is $0.00 as on 08 Feb '26.